Clinical Trials Directory

Trials / Completed

CompletedNCT03503045

The Rates of Overtreatment and Deintensification in Patients With Diabetes Mellitus

The Rates of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Patients With Diabetes Mellitus

Status
Completed
Phase
Study type
Observational
Enrollment
1,276 (actual)
Sponsor
Gulhane School of Medicine · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the overtreatment and deintensification rates of antidiabetic and antihypertensive medications in patients with diabetes mellitus in Turkey.

Detailed description

Diabetes mellitus is one of the most common chronic diseases which lead to serious public health problems and a significant economic burden worldwide. The prevalence of diabetes in elderly patients is very high and is predicted to increase dramatically. Prior studies have generally been concerned with the inadequate treatment of diabetes however, over the last few years the overtreatment of diabetes has also come to the fore. Unfortunately, there are very few data worldwide and no data in Turkey about the overtreatment of patients with type 2 diabetes. This study aimed to assess the rates and predictors of overtreatment and undertreatment of glycemia and blood pressure in older adults with T2DM. Treatment deintensification or intensification by the physicians were also investigated.

Conditions

Timeline

Start date
2017-04-01
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2018-04-19
Last updated
2019-02-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03503045. Inclusion in this directory is not an endorsement.

The Rates of Overtreatment and Deintensification in Patients With Diabetes Mellitus (NCT03503045) · Clinical Trials Directory